A lawyer for a man who said his cancer was caused by Bayer AG’s glyphosate-based weed killer Roundup on Tuesday urged U.S. jurors to “send a message” to the company by holding it liable and awarding millions in damages, Reuters reported.
The case is only the second of more than 11,200 Roundup lawsuits to go to trial in the U.S. as litigation setbacks and a prior jury verdict against the company have sent Bayer shares plunging.
“A responsible company would test its product. A responsible company would tell their customers if they knew it causes cancer,” Aimee Wagstaff, a lawyer for plaintiff Edwin Hardeman, was quoted as saying during closing arguments on Tuesday. She called conduct by Bayer’s Monsanto unit reckless and offensive.
Bayer, which bought Roundup maker Monsanto in a US$63 billion deal last year, denies the allegations, saying decades of studies by independent scientists have shown glyphosate and Roundup to be safe for human use.
In Hardeman’s case, the jury on March 19 found Roundup to have been a “substantial factor” in causing his non-Hodgkin’s lymphoma. That verdict followed a first phase of the trial that focused exclusively on science. The decision allowed the trial to proceed to a second phase in which the same jury will decide if Bayer is liable.
In the second phase lawyers for Hardeman were able to present previously excluded internal documents allegedly showing the company’s efforts to influence scientists and regulators about the popular product’s safety.
Jurors will now decide whether Roundup was defectively designed, whether Monsanto acted negligently, and if it failed to warn consumers of Roundup’s cancer risks. If jurors find the company liable, they can award compensatory and punitive damages.
Monsanto and Bayer have continued to argue that Roundup is safe to use and does not cause cancer.